Results 11 to 20 of about 3,517,895 (261)
Korean Gastric Cancer Association- Led Nationwide Survey on Surgically Treated Gastric Cancers in 2019 [PDF]
, 2021 Purpose: The Korean Gastric Cancer Association (KGCA) has been conducting nationwide surveys on patients with surgically treated gastric cancer, every 5 years, since 1995. This study details the results of the survey conducted in 2019.
권인규
core +1 more source
A Standardized Pathology Report for Gastric Cancer: 2nd Edition [PDF]
, 2023 The first edition of ‘A Standardized Pathology Report for Gastric Cancer’ was initiated by the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists and published 17 years ago. Since then, significant advances have been made in the
김현기, 최윤정
core +1 more source
Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach [PDF]
, 2023 Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this is the 4th gastric cancer guideline published in Korea which is the revised version of previous evidence-based approach in 2018.
정민규 +3 more
core +1 more source
Chylous Ascites After Gastric Cancer Surgery: Risk Factors and Treatment Results [PDF]
, 2023 Purpose: Although chylous ascites is a frequent complication of radical gastrectomy for gastric cancer, proper diagnostic criteria and optimal treatment strategies have not been established.
박성현 +5 more
core +1 more source
BMC Surgery, 2021 Objective Proximal gastrectomy acts as a function-preserving operation for upper-third gastric cancer. The aim of this study was to compare the short-term surgical outcomes between proximal gastrectomy with gastric tube reconstruction and proximal ...
Zhiguo Li +4 more
doaj +1 more source
Molecular diagnosis for personalized target therapy in gastric cancer [PDF]
, 2013 Gastric cancer is the second leading cause of cancer-related deaths worldwide. In advanced and metastatic gastric cancer, the conventional chemotherapy with limited efficacy shows an overall survival period of about 10 months.
조재용
core +1 more source
Long-Term Survival Outcomes of Elderly Patients Treated With S-1 or Capecitabine Plus Oxaliplatin for Stage II or III Gastric Cancer: A Multicenter Cohort Study [PDF]
, 2022 Purpose: Tegafur/gimeracil/oteracil (S-1) and capecitabine plus oxaliplatin (CAPOX) are standard adjuvant chemotherapies (ACs) administered after gastrectomy to patients with stage II or III gastric cancer. However, the efficacy of AC in elderly patients
김형일
core +1 more source
World Journal of Surgical Oncology, 2020 Background During esophagectomy for esophageal cancer, a gastric tube is necessary for the perioperative period. However, the gastric tube and anastomotic anvil placement is often extremely difficult and time consuming during surgery. Methods We used the
Yi Shen, Yunfeng Zhou, Xiang Zhuang
doaj +1 more source
Eupatilin Inhibits Gastric Cancer Cell Growth by Blocking STAT3-Mediated VEGF Expression [PDF]
, 2011 Purpose: Eupatilin is an antioxidative flavone and a phytopharmaceutical derived from Artemisia asiatica. It has been reported to possess anti-tumor activity in some types of cancer including gastric cancer.
Yanjun Zheng +5 more
core +1 more source
Arquivos de Gastroenterologia, 2015 Background Stent palliation is the gold standard for gastric/duodenal cancer outlet obstruction. When stenting is impossible, feeding may be achieved through a gastrojejunostomy (PEG-J), but displacement of jejunal tube is frequent due to manipulation ...
Jorge FONSECA, Carla Adriana SANTOS
doaj +1 more source